These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4032422)

  • 1. Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1181-7. PubMed ID: 4032422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.
    Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM
    J Med Chem; 1986 Mar; 29(3):328-33. PubMed ID: 3950913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group.
    Wissner A; Kohler CA; Goldstein BM
    J Med Chem; 1985 Sep; 28(9):1365-7. PubMed ID: 4032438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
    Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
    J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis and physiological activity of sulfonium analogues of platelet activating factor.
    Kates M; Adams GA; Blank ML; Snyder F
    Lipids; 1991 Dec; 26(12):1095-101. PubMed ID: 1819693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain.
    Wissner A; Sum PE; Schaub RE; Kohler CA; Goldstein BM
    J Med Chem; 1984 Sep; 27(9):1174-81. PubMed ID: 6471071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of bioisosteric O-carba-analogues of platelet activating factor (PAF).
    Nakamura N; Miyazaki H; Ohkawa N; Koike H; Sada T; Asai F; Kobayashi S
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2452-5. PubMed ID: 6488414
    [No Abstract]   [Full Text] [Related]  

  • 8. Analogues of platelet activating factor. 5. Multiple oxygen substitution of the alkoxy chain.
    Wissner A; Kohler CA; Goldstein BM
    J Med Chem; 1986 Jul; 29(7):1315-9. PubMed ID: 3806583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
    Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine.
    Schmid B; Ostermann G; Kertscher HP
    Chem Phys Lipids; 1991 Nov; 60(1):77-82. PubMed ID: 1813180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
    Hofmann B; Ostermann G; Kertscher HP; Till U
    Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of antibodies to platelet-activating factor.
    Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA
    J Lipid Mediat; 1992 Feb; 5(1):49-59. PubMed ID: 1391739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactone and cyclic ether analogues of platelet-activating factor. Synthesis and biological activities.
    Miyazaki H; Ohkawa N; Nakamura N; Ito T; Sada T; Oshima T; Koike H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2379-90. PubMed ID: 2605681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
    Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
    Grue-Sørensen G; Nielsen IM; Nielsen CK
    J Med Chem; 1988 Jun; 31(6):1174-8. PubMed ID: 3373485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M; Coëffier E; Polonsky J; Benveniste J
    Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive actions of some analogues of platelet-activating factor (PAF) with higher potencies than natural PAF.
    Kasuya Y; Masuda Y; Shigenobu K
    Can J Physiol Pharmacol; 1984 Apr; 62(4):457-9. PubMed ID: 6733593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F; Steiner E; Jouquey S; Godfroid JJ
    J Lipid Mediat; 1989; 1(5):303-12. PubMed ID: 2562436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral PAF agonists: synthesis, theoretical analysis of their stereoelectronic properties and structure activity relationships.
    Villa L; Pallavicini M; Villa AM; Valoti E; Ferri V; Maderna P
    Farmaco; 1993 May; 48(5):573-613. PubMed ID: 8343209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.